{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:32Z","timestamp":1791919592461,"version":"4.3.4"},"reference-count":216,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03283-5","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:02:15Z","timestamp":1763683335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nanocarrier Strategies in Glioblastoma: Overcoming Barriers to Effective Brain Tumor Therapy"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0424-7535","authenticated-orcid":false,"given":"Sara","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-8181","authenticated-orcid":false,"given":"Md. Faheem","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2021-4450","authenticated-orcid":false,"given":"Safia Obaidur","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"2","key":"3283_CR1","first-page":"97","volume":"8","author":"N Tzenios","year":"2023","unstructured":"Tzenios N. Obesity as a risk factor for different types of cancer. EPRA International Journal of Research and Development (IJRD). 2023;8(2):97\u2013100.","journal-title":"EPRA International Journal of Research and Development (IJRD)"},{"issue":"2","key":"3283_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0318194","volume":"20","author":"R Kiss-Miki","year":"2025","unstructured":"Kiss-Miki R, Obeidat M, M\u00e1t\u00e9 V, Teutsch B, Ag\u00f3cs G, Kiss-Dala S, et al. Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: a systematic review and meta-analysis. PLoS One. 2025;20(2):e0318194.","journal-title":"PLoS One"},{"issue":"1","key":"3283_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1515\/folmed-2017-0069","volume":"60","author":"GS Stoyanov","year":"2018","unstructured":"Stoyanov GS, Dzhenkov DL. On the concepts and history of glioblastoma multiforme\u2014morphology, genetics and epigenetics. Folia Med. 2018;60(1):48\u201366.","journal-title":"Folia Med"},{"key":"3283_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.wneu.2021.02.047","volume":"149","author":"IE McCutcheon","year":"2021","unstructured":"McCutcheon IE, Preul MC. Historical perspective on surgery and survival with glioblastoma: how far have we come? World Neurosurg. 2021;149:148\u201368.","journal-title":"World Neurosurg"},{"key":"3283_CR5","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1016\/j.wneu.2023.04.104","volume":"175","author":"P Paul","year":"2023","unstructured":"Paul P, Banerjee M. A comprehensive view (COUP D\u2019OEIL) of brain tumors from Eastern India. World Neurosurg. 2023;175:e1237\u201345.","journal-title":"World Neurosurg"},{"key":"3283_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/011574888X341525250116052000","author":"K Singh","year":"2025","unstructured":"Singh K, Singh G, Gupta JK, Choudhary AN, Kumar A, Jain D, et al. Molecular mechanisms and pathways of mesenchymal stem cell-mediated therapy in brain cancer. Curr Stem Cell Res Ther. 2025. https:\/\/doi.org\/10.2174\/011574888X341525250116052000.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"8","key":"3283_CR7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/neuonc\/noae072","volume":"26","author":"R Rahman","year":"2024","unstructured":"Rahman R, Shi DD, Reitman ZJ, Hamerlik P, De Groot JF, Haas-Kogan DA, et al. DNA damage response in brain tumors: a Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology. Neuro-Oncol. 2024;26(8):1367\u201387.","journal-title":"Neuro-Oncol"},{"key":"3283_CR8","doi-asserted-by":"crossref","unstructured":"Guler, E. M., Koc, S., Dumlu, F. S., Beyaztas, H., Ozkan, B. N., & Bozali, K. (2024). Brain cancer stem cells: overview and potential targeted therapy.\u00a0Cancer Stem Cells and Signaling Pathways, 351\u2013361.","DOI":"10.1016\/B978-0-443-13212-4.00014-3"},{"key":"3283_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.659055","volume":"9","author":"RN Curry","year":"2021","unstructured":"Curry RN, Glasgow SM. The role of neurodevelopmental pathways in brain tumors. Front Cell Dev Biol. 2021;9:659055.","journal-title":"Front Cell Dev Biol"},{"issue":"22","key":"3283_CR10","doi-asserted-by":"publisher","first-page":"33440","DOI":"10.18632\/oncotarget.7961","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Wu C, Chen N, Gu H, Yen A, Cao L, et al. PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440.","journal-title":"Oncotarget"},{"key":"3283_CR11","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s13277-013-0800-5","volume":"34","author":"A Sami","year":"2013","unstructured":"Sami A, Karsy M. Targeting the PI3K\/AKT\/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding. Tumor Biol. 2013;34:1991\u20132002.","journal-title":"Tumor Biol"},{"issue":"3","key":"3283_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031353","volume":"23","author":"A Barzegar Behrooz","year":"2022","unstructured":"Barzegar Behrooz A, Talaie Z, Jusheghani F, \u0141os MJ, Klonisch T, Ghavami S. Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma. Int J Mol Sci. 2022;23(3):1353.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3283_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.gene.2014.06.042","volume":"547","author":"W Li","year":"2014","unstructured":"Li W, Li K, Zhao L, Zou H. Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in glioblastoma multiforme. Gene. 2014;547(2):346\u201350.","journal-title":"Gene"},{"issue":"2","key":"3283_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020587","volume":"22","author":"A Oprita","year":"2021","unstructured":"Oprita A, Baloi SC, Staicu GA, Alexandru O, Tache DE, Danoiu S, et al. Updated insights on EGFR signaling pathways in glioma. Int J Mol Sci. 2021;22(2):587.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3283_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/neuonc\/nos299","volume":"15","author":"KH Kim","year":"2013","unstructured":"Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, et al. Wnt\/\u03b2-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro-oncol. 2013;15(2):161\u201371.","journal-title":"Neuro-oncol"},{"issue":"3","key":"3283_CR16","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/jcp.27186","volume":"234","author":"L He","year":"2019","unstructured":"He L, Zhou H, Zeng Z, Yao H, Jiang W, Qu H. Wnt\/\u03b2-catenin signaling cascade: a promising target for glioma therapy. J Cell Physiol. 2019;234(3):2217\u201328.","journal-title":"J Cell Physiol"},{"key":"3283_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2119\/molmed.2010.00062","volume":"17","author":"IV Ulasov","year":"2011","unstructured":"Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133+ glioma stem cells to temozolomide therapy. Mol Med. 2011;17:103\u201312.","journal-title":"Mol Med"},{"issue":"3","key":"3283_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030292","volume":"11","author":"R Bazzoni","year":"2019","unstructured":"Bazzoni R, Bentivegna A. Role of notch signaling pathway in glioblastoma pathogenesis. Cancers (Basel). 2019;11(3):292.","journal-title":"Cancers (Basel)"},{"key":"3283_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11060-005-9103-z","volume":"78","author":"RL Jensen","year":"2006","unstructured":"Jensen RL, Ragel BT, Whang K, Gillespie D. Inhibition of hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol. 2006;78:233\u201347.","journal-title":"J Neurooncol"},{"issue":"11","key":"3283_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1593\/neo.06535","volume":"8","author":"N Pore","year":"2006","unstructured":"Pore N, Gupta AK, Cerniglia GJ, Maity A. HIV protease inhibitors decrease VEGF\/HIF-1\u03b1 expression and angiogenesis in glioblastoma cells. Neoplasia. 2006;8(11):889\u201395.","journal-title":"Neoplasia"},{"issue":"3","key":"3283_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aar2766","volume":"4","author":"FL Ricklefs","year":"2018","unstructured":"Ricklefs FL, Alayo Q, Krenzlin H, Mahmoud AB, Speranza MC, Nakashima H, et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv. 2018;4(3):eaar2766.","journal-title":"Sci Adv"},{"issue":"3","key":"3283_CR22","doi-asserted-by":"publisher","first-page":"E98","DOI":"10.1093\/neuros\/nyy295","volume":"83","author":"JA Lubin","year":"2018","unstructured":"Lubin JA, Zhang RR, Kuo JS. Extracellular vesicles containing PD-L1 contribute to immune evasion in glioblastoma. Neurosurgery. 2018;83(3):E98-100.","journal-title":"Neurosurgery"},{"issue":"11","key":"3283_CR23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191115","volume":"217","author":"L Du","year":"2020","unstructured":"Du L, Lee JH, Jiang H, Wang C, Wang S, Zheng Z, et al. \u03b2-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion. J Exp Med. 2020;217(11):e20191115.","journal-title":"J Exp Med"},{"key":"3283_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ. Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36:437\u201349.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"3283_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm87010006","volume":"87","author":"LA Bors","year":"2019","unstructured":"Bors LA, Erd\u0151 F. Overcoming the blood\u2013brain barrier. Challenges and tricks for CNS drug delivery. Sci Pharm. 2019;87(1):6.","journal-title":"Sci Pharm"},{"issue":"1","key":"3283_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/17435889.2024.2421157","volume":"20","author":"AG Almutary","year":"2025","unstructured":"Almutary AG, Chauhan P, Baldaniya L, Menon SV, Kumar MR, Chaturvedi B, et al. Overcoming challenges in the design of drug delivery systems targeting the central nervous system. Nanomedicine. 2025;20(1):5\u20138.","journal-title":"Nanomedicine"},{"issue":"3","key":"3283_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032710","volume":"24","author":"B Chaulagain","year":"2023","unstructured":"Chaulagain B, Gothwal A, Lamptey RNL, Trivedi R, Mahanta AK, Layek B, et al. Experimental models of in vitro blood\u2013brain barrier for CNS drug delivery: an evolutionary perspective. Int J Mol Sci. 2023;24(3):2710.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3283_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/S41568-019-0205-X","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20(1):26\u201341. https:\/\/doi.org\/10.1038\/S41568-019-0205-X.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3283_CR29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1586\/14737175.6.8.1199","volume":"6","author":"NA Vries","year":"2006","unstructured":"Vries NA, Beijnen JH, Boogerd W, van Tellingen O. Blood-brain barrier and chemotherapeutic treatment of brain tumors. Expert Rev Neurother. 2006;6(8):1199\u2013209. https:\/\/doi.org\/10.1586\/14737175.6.8.1199.","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"3283_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/14737175.2016.1202761","volume":"16","author":"A Dr\u00e9an","year":"2016","unstructured":"Dr\u00e9an A, Goldwirt L, Verreault M, Canney M, Schmitt C, Guehennec J, et al. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma. Expert Rev Neurother. 2016;16(11):1285\u2013300.","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"3283_CR31","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.7150\/thno.69682","volume":"12","author":"DH Upton","year":"2022","unstructured":"Upton DH, Ung C, George SM, Tsoli M, Kavallaris M, Ziegler DS. Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. Theranostics. 2022;12(10):4734.","journal-title":"Theranostics"},{"issue":"5","key":"3283_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11050245","volume":"11","author":"A Parodi","year":"2019","unstructured":"Parodi A, Rudzi\u0144ska M, Deviatkin AA, Soond SM, Baldin AV, Zamyatnin AA Jr. Established and emerging strategies for drug delivery across the blood-brain barrier in brain cancer. Pharmaceutics. 2019;11(5):245.","journal-title":"Pharmaceutics"},{"key":"3283_CR33","doi-asserted-by":"crossref","unstructured":"Johanson, C. E., Stopa, E. G., & McMillan, P. N. (2011). The blood\u2013cerebrospinal fluid barrier: structure and functional significance.\u00a0The blood-brain and other neural barriers: Reviews and protocols, 101\u2013131.","DOI":"10.1007\/978-1-60761-938-3_4"},{"key":"3283_CR34","doi-asserted-by":"crossref","unstructured":"Engelhardt, B., & Sorokin, L. (2009, November). The blood\u2013brain and the blood\u2013cerebrospinal fluid barriers: function and dysfunction. In\u00a0Seminars in immunopathology.\u00a0Vol. 31: pp. 497\u2013511. Springer-Verlag.","DOI":"10.1007\/s00281-009-0177-0"},{"key":"3283_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS. 2011;8:1\u201325.","journal-title":"Fluids Barriers CNS"},{"issue":"Suppl 7","key":"3283_CR36","doi-asserted-by":"publisher","first-page":"vii21","DOI":"10.1093\/neuonc\/noac209.083","volume":"24","author":"J Neman","year":"2022","unstructured":"Neman J, Saatian B, Deshpande K, Martisorian V, LaViolette P, Boire A, et al. CNSC-02. Breast to brain metastasis is exacerbated with chemotherapy through blood-cerebral spinal fluid-barrier and induces Alzheimer\u2019s-like pathology. Neuro-Oncol. 2022;24(Suppl 7):vii21.","journal-title":"Neuro-Oncol"},{"issue":"12","key":"3283_CR37","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/jnr.25249","volume":"101","author":"B Saatian","year":"2023","unstructured":"Saatian B, Deshpande K, Herrera R, Sedighi S, Eisenbarth R, Iyer M, et al. Breast-to-brain metastasis is exacerbated with chemotherapy through blood\u2013cerebrospinal fluid barrier and induces Alzheimer\u2019s-like pathology. J Neurosci Res. 2023;101(12):1900\u201313.","journal-title":"J Neurosci Res"},{"issue":"4","key":"3283_CR38","volume":"5","author":"RA Herrera","year":"2022","unstructured":"Herrera RA, Deshpande K, Martirosian V, Saatian B, Julian A, Eisenbarth R, et al. Cortisol promotes breast-to-brain metastasis through the blood-cerebrospinal fluid barrier. Cancer Rep. 2022;5(4):e1351.","journal-title":"Cancer Rep"},{"issue":"1","key":"3283_CR39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1080\/10717544.2022.2069881","volume":"29","author":"X Wang","year":"2022","unstructured":"Wang X, Wu C, Liu S, Peng D. Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives. Drug Deliv. 2022;29(1):1370\u201383.","journal-title":"Drug Deliv"},{"key":"3283_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11910-008-0036-8","volume":"8","author":"J Blakeley","year":"2008","unstructured":"Blakeley J. Drug delivery to brain tumors. Curr Neurol Neurosci Rep. 2008;8:235\u201341.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"3283_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/VIW.20200129","volume":"3","author":"Y Song","year":"2022","unstructured":"Song Y, Hu C, Fu Y, Gao H. Modulating the blood\u2013brain tumor barrier for improving drug delivery efficiency and efficacy. View. 2022;3(1):20200129.","journal-title":"View"},{"issue":"1","key":"3283_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","volume":"26","author":"D Wang","year":"2019","unstructured":"Wang D, Wang C, Wang L, Chen Y. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment. Drug Deliv. 2019;26(1):551\u201365.","journal-title":"Drug Deliv"},{"issue":"10","key":"3283_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102391","volume":"13","author":"F Marcucci","year":"2021","unstructured":"Marcucci F, Corti A, Ferreri AJ. Breaching the blood\u2013brain tumor barrier for tumor therapy. Cancers (Basel). 2021;13(10):2391.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3283_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10717544.2022.2154409","volume":"30","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yue P, Peng Y, Sun Y, Chen X, Zhao Z, et al. Recent advances in drug delivery systems for targeting brain tumors. Drug Deliv. 2023;30(1):1\u201318.","journal-title":"Drug Deliv"},{"key":"3283_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","volume":"19","author":"O Van Tellingen","year":"2015","unstructured":"Van Tellingen O, Yetkin-Arik B, De Gooijer MC, Wesseling P, Wurdinger T, De Vries HE. Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1\u201312.","journal-title":"Drug Resist Updat"},{"key":"3283_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1433453","volume":"4","author":"SF Hathcock","year":"2024","unstructured":"Hathcock SF, Knight HE, Tong EG, Meyer AE, Mauser HD, Vollmuth N, et al. Induction of P-glycoprotein overexpression in brain endothelial cells as a model to study blood-brain barrier efflux transport. Frontiers in Drug Delivery. 2024;4:1433453.","journal-title":"Frontiers in Drug Delivery"},{"issue":"10","key":"3283_CR47","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2174\/13816128113199990463","volume":"20","author":"L Sanchez-Covarrubias","year":"2014","unstructured":"Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des. 2014;20(10):1422\u201349.","journal-title":"Curr Pharm Des"},{"key":"3283_CR48","doi-asserted-by":"crossref","unstructured":"Kusuhara, H., & Sugiyama, Y. (2005, April). Efflux transport systems at the blood\u2013brain barrier and blood CSF barrier. In\u00a0International congress series\u00a0(Vol. 1277, pp. 111\u2013122). Elsevier.","DOI":"10.1016\/j.ics.2005.02.015"},{"issue":"1","key":"3283_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/bdd.2331","volume":"44","author":"B Cox","year":"2023","unstructured":"Cox B, Nicola\u00ef J, Williamson B. The role of the efflux transporter, P-glycoprotein, at the blood\u2013brain barrier in drug discovery. Biopharm Drug Dispos. 2023;44(1):113\u201326.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"3283_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0169-409X(02)00172-2","volume":"55","author":"H Sun","year":"2003","unstructured":"Sun H, Dai H, Shaik N, Elmquist WF. Drug efflux transporters in the CNS. Adv Drug Deliv Rev. 2003;55(1):83\u2013105.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3283_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052529","volume":"25","author":"E Obrador","year":"2024","unstructured":"Obrador E, Moreno-Murciano P, Oriol-Caballo M, L\u00f3pez-Blanch R, Pineda B, Guti\u00e9rrez-Arroyo JL, et al. Glioblastoma therapy: past, present and future. Int J Mol Sci. 2024;25(5):2529.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3283_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41578-024-00684-z","volume":"9","author":"F Hameedat","year":"2024","unstructured":"Hameedat F, Mendes BB, Conniot J, Di Filippo LD, Chorilli M, Schroeder A, et al. Engineering nanomaterials for glioblastoma nanovaccination. Nat Rev Mater. 2024;9(9):628\u201342.","journal-title":"Nat Rev Mater"},{"issue":"8","key":"3283_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081485","volume":"16","author":"SA Rios","year":"2024","unstructured":"Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J, et al. Emerging therapies for glioblastoma. Cancers (Basel). 2024;16(8):1485.","journal-title":"Cancers (Basel)"},{"issue":"14","key":"3283_CR54","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/14656566.2022.2125302","volume":"23","author":"E Aquilanti","year":"2022","unstructured":"Aquilanti E, Wen PY. Current therapeutic options for glioblastoma and future perspectives. Expert Opin Pharmacother. 2022;23(14):1629\u201340.","journal-title":"Expert Opin Pharmacother"},{"key":"3283_CR55","doi-asserted-by":"crossref","unstructured":"Khan, S., Haider, M. F., & Naseem, N. (2025) An overview and applications of nanocarriers based drug delivery in alleviating Alzheimer\u2019s disease.\u00a0Journal of Bio-X Research.","DOI":"10.34133\/jbioxresearch.0042"},{"key":"3283_CR56","doi-asserted-by":"crossref","unstructured":"Khan, S., & Haider, M. F. (2024). A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson\u2019s Disease: An Updated Patent and Clinical Trials.\u00a0CNS & Neurological Disorders-Drug Targets.","DOI":"10.2174\/0118715273323074241001071645"},{"key":"3283_CR57","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S333657","author":"BS Alotaibi","year":"2021","unstructured":"Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Noreen S, et al. Potential of nanocarrier-based drug delivery systems for brain targeting: a current review of literature. Int J Nanomedicine. 2021. https:\/\/doi.org\/10.2147\/IJN.S333657.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3283_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010204","volume":"14","author":"MG Montiel Schneider","year":"2022","unstructured":"Montiel Schneider MG, Mart\u00edn MJ, Otarola J, Vakarelska E, Simeonov V, Lassalle V, et al. Biomedical applications of iron oxide nanoparticles: current insights progress and perspectives. Pharmaceutics. 2022;14(1):204.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3283_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-025-06268-4","volume":"27","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li W, Zhou J, Yu Y, Liu S, Xu Q. Characterization and in vitro cellular activity assessment of photodynamic composite nanocarriers for gliomas treatment. J Nanopart Res. 2025;27(3):1\u201312.","journal-title":"J Nanopart Res"},{"issue":"6","key":"3283_CR60","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3109\/03639045.2014.920025","volume":"41","author":"B Khameneh","year":"2015","unstructured":"Khameneh B, Iranshahy M, Ghandadi M, Ghoochi Atashbeyk D, Fazly Bazzaz BS, Iranshahi M. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus. Drug Dev Ind Pharm. 2015;41(6):989\u201394.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"3283_CR61","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/03639045.2013.877483","volume":"41","author":"N Moghadas-Sharif","year":"2015","unstructured":"Moghadas-Sharif N, Fazly Bazzaz BS, Khameneh B, Malaekeh-Nikouei B. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm. Drug Dev Ind Pharm. 2015;41(3):445\u201350.","journal-title":"Drug Dev Ind Pharm"},{"key":"3283_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejps.2016.03.009","volume":"86","author":"M Zahmatkeshan","year":"2016","unstructured":"Zahmatkeshan M, Gheybi F, Rezayat SM, Jaafari MR. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model. Eur J Pharm Sci. 2016;86:125\u201335.","journal-title":"Eur J Pharm Sci"},{"key":"3283_CR63","doi-asserted-by":"crossref","unstructured":"Agrawal, M., Tripathi, D. K., Saraf, S., Saraf, S., Antimisiaris, S. G., Mourtas, S., ... & Alexander, A. (2017). Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease.\u00a0J control release.\u00a0260:61\u201377.","DOI":"10.1016\/j.jconrel.2017.05.019"},{"issue":"5","key":"3283_CR64","first-page":"1949","volume":"6","author":"D Goren","year":"2000","unstructured":"Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res. 2000;6(5):1949\u201357.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3283_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jconrel.2006.06.010","volume":"114","author":"RI Pakunlu","year":"2006","unstructured":"Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Control Release. 2006;114(2):153\u201362.","journal-title":"J Control Release"},{"issue":"1","key":"3283_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1872210513666181127110413","volume":"13","author":"R Sheoran","year":"2019","unstructured":"Sheoran R, Khokra SL, Chawla V, Dureja H. Recent patents, formulation techniques, classification and characterization of liposomes. Recent Pat Nanotechnol. 2019;13(1):17\u201327.","journal-title":"Recent Pat Nanotechnol"},{"key":"3283_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2020.105008","volume":"234","author":"A Papagiannopoulos","year":"2021","unstructured":"Papagiannopoulos A, Pippa N, Demetzos C, Pispas S, Radulescu A. Lamellarity and size distributions in mixed DPPC\/amphiphilic poly (2-oxazoline) gradient copolymer vesicles and their temperature response. Chem Phys Lipids. 2021;234:105008.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"3283_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00912-6","volume":"19","author":"M Di Muzio","year":"2021","unstructured":"Di Muzio M, Millan-Solsona R, Dols-Perez A, Borrell JH, Fumagalli L, Gomila G. Dielectric properties and lamellarity of single liposomes measured by in-liquid scanning dielectric microscopy. J Nanobiotechnology. 2021;19(1):167.","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"3283_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","volume":"154","author":"A Sharma","year":"1997","unstructured":"Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154(2):123\u201340.","journal-title":"Int J Pharm"},{"issue":"8","key":"3283_CR70","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ctrv.2011.01.006","volume":"37","author":"F Yang","year":"2011","unstructured":"Yang F, Jin C, Jiang Y, Li J, Di Y, Ni Q, et al. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer Treat Rev. 2011;37(8):633\u201342.","journal-title":"Cancer Treat Rev"},{"key":"3283_CR71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jiec.2019.01.021","volume":"73","author":"J Kim","year":"2019","unstructured":"Kim J, Ahn SI, Kim Y. Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system. J Ind Eng Chem. 2019;73:8\u201318.","journal-title":"J Ind Eng Chem"},{"issue":"3","key":"3283_CR72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1517\/17425247.2016.1121987","volume":"13","author":"SH Alavizadeh","year":"2016","unstructured":"Alavizadeh SH, Akhtari J, Badiee A, Golmohammadzadeh S, Jaafari MR. Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models. Expert Opin Drug Deliv. 2016;13(3):325\u201336.","journal-title":"Expert Opin Drug Deliv"},{"key":"3283_CR73","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","volume":"42","author":"A Gabizon","year":"2003","unstructured":"Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003;42:419\u201336.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"3283_CR74","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/adacef","volume":"36","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qi P, Shi S, Pang C, Wang W, Fang D. Targeted therapy for glioblastoma utilizing hyaluronic acid-engineered liposomes for adriamycin delivery. Nanotechnology. 2025;36(12):125102.","journal-title":"Nanotechnology"},{"issue":"7","key":"3283_CR75","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/1389201017666160401144440","volume":"17","author":"X Chen","year":"2016","unstructured":"Chen X, Yuan M, Zhang Q, Ting Yang Y, Gao H, He Q. Synergistic combination of doxorubicin and paclitaxel delivered by blood brain barrier and glioma cells dual targeting liposomes for chemotherapy of brain glioma. Curr Pharm Biotechnol. 2016;17(7):636\u201350.","journal-title":"Curr Pharm Biotechnol"},{"issue":"38","key":"3283_CR76","doi-asserted-by":"publisher","first-page":"21442","DOI":"10.1021\/acsami.5b06429","volume":"7","author":"K Shi","year":"2015","unstructured":"Shi K, Long Y, Xu C, Wang Y, Qiu Y, Yu Q, et al. Liposomes combined an integrin \u03b1v\u03b23-specific vector with ph-responsible cell-penetrating property for highly effective antiglioma therapy through the blood\u2013brain barrier. ACS Appl Mater Interfaces. 2015;7(38):21442\u201354.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"3283_CR77","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/mp800218q","volume":"6","author":"J Du","year":"2009","unstructured":"Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, et al. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood\u2212 brain barrier and survival of brain tumor-bearing animals. Mol Pharm. 2009;6(3):905\u201317.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"3283_CR78","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpharm.2016.04.046","volume":"506","author":"T Fukuta","year":"2016","unstructured":"Fukuta T, Asai T, Sato A, Namba M, Yanagida Y, Kikuchi T, et al. Neuroprotection against cerebral ischemia\/reperfusion injury by intravenous administration of liposomal fasudil. Int J Pharm. 2016;506(1\u20132):129\u201337.","journal-title":"Int J Pharm"},{"issue":"1","key":"3283_CR79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/1566524018666180416101522","volume":"18","author":"A Jain","year":"2018","unstructured":"Jain A, Jain SK. Advances in tumor targeted liposomes. Curr Mol Med. 2018;18(1):44\u201357.","journal-title":"Curr Mol Med"},{"issue":"26","key":"3283_CR80","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.7150\/thno.37198","volume":"9","author":"J Park","year":"2019","unstructured":"Park J, Choi Y, Chang H, Um W, Ryu JH, Kwon IC. Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment. Theranostics. 2019;9(26):8073.","journal-title":"Theranostics"},{"key":"3283_CR81","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","volume":"98","author":"D Kalyane","year":"2019","unstructured":"Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl. 2019;98:1252\u201376.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"17","key":"3283_CR82","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.7150\/thno.49577","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi Y, Van der Meel R, Chen X, Lammers T. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics. 2020;10(17):7921.","journal-title":"Theranostics"},{"issue":"3","key":"3283_CR83","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/1535-7163.MCT-08-0853","volume":"8","author":"AB Madhankumar","year":"2009","unstructured":"Madhankumar AB, Slagle-Webb B, Wang X, Yang QX, Antonetti DA, Miller PA, et al. Efficacy of interleukin-13 receptor\u2013targeted liposomal doxorubicin in the intracranial brain tumor model. Mol Cancer Ther. 2009;8(3):648\u201354.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"3283_CR84","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jconrel.2012.02.023","volume":"160","author":"FY Yang","year":"2012","unstructured":"Yang FY, Wong TT, Teng MC, Liu RS, Lu M, Liang HF, et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release. 2012;160(3):652\u20138.","journal-title":"J Control Release"},{"issue":"2","key":"3283_CR85","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijpharm.2015.01.016","volume":"479","author":"YDP Limasale","year":"2015","unstructured":"Limasale YDP, Tezcaner A, \u00d6zen C, Keskin D, Banerjee S. Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells. Int J Pharm. 2015;479(2):364\u201373.","journal-title":"Int J Pharm"},{"issue":"22","key":"3283_CR86","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","volume":"34","author":"JQ Gao","year":"2013","unstructured":"Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, et al. Glioma targeting and blood\u2013brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials. 2013;34(22):5628\u201339.","journal-title":"Biomaterials"},{"issue":"10","key":"3283_CR87","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1054\/bjoc.2000.1459","volume":"83","author":"MI Koukourakis","year":"2000","unstructured":"Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, et al. High intratumoural accumulation of stealth\u00ae liposomal doxorubicin (Caelyx\u00ae) in glioblastomas and in metastatic brain tumours. Br J Cancer. 2000;83(10):1281\u20136.","journal-title":"Br J Cancer"},{"issue":"12","key":"3283_CR88","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/1535-7163.MCT-06-0480","volume":"5","author":"AB Madhankumar","year":"2006","unstructured":"Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR. Interleukin-13 receptor\u2013targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol Cancer Ther. 2006;5(12):3162\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3283_CR89","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijrobp.2011.10.054","volume":"84","author":"G Charest","year":"2012","unstructured":"Charest G, Sanche L, Fortin D, Mathieu D, Paquette B. Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy. Int J Radiat Oncol Biol Phys. 2012;84(1):244\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3283_CR90","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jgm.255","volume":"4","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Jeong Lee H, Boado RJ, Pardridge WM. Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med. 2002;4(2):183\u201394.","journal-title":"J Gene Med"},{"key":"3283_CR91","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/B:NEON.0000003655.03671.fa","volume":"65","author":"J Yoshida","year":"2003","unstructured":"Yoshida J, Mizuno M. Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma. J Neuro-Oncol. 2003;65:261\u20137.","journal-title":"J Neuro-Oncol"},{"key":"3283_CR92","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"3283_CR93","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1023\/A:1005903002865","volume":"39","author":"N Sugawa","year":"1998","unstructured":"Sugawa N, Ueda S, Nakagawa Y, Nishino H, Nosaka K, Iwashima A, et al. An antisense EGFR oligodeoxynucleotide enveloped in lipofectin R induces growth inhibition in human malignant gliomas in vitro. J Neurooncol. 1998;39:237\u201344.","journal-title":"J Neurooncol"},{"issue":"2","key":"3283_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1461-5347(98)00117-5","volume":"2","author":"WM Pardridge","year":"1999","unstructured":"Pardridge WM. Non-invasive drug delivery to the human brain using endogenous blood\u2013brain barrier transport systems. Pharmaceutical Science & Technology Today. 1999;2(2):49\u201359.","journal-title":"Pharmaceutical Science & Technology Today"},{"issue":"1","key":"3283_CR95","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","volume":"47","author":"AG De Boer","year":"2007","unstructured":"De Boer AG, Gaillard PJ. Drug targeting to the brain. Annu Rev Pharmacol Toxicol. 2007;47(1):323\u201355.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3283_CR96","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1023\/A:1007592720793","volume":"17","author":"MJ Coloma","year":"2000","unstructured":"Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, et al. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res. 2000;17:266\u201374.","journal-title":"Pharm Res"},{"key":"3283_CR97","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221080974","volume":"21","author":"A Mehrabian","year":"2022","unstructured":"Mehrabian A, Mashreghi M, Dadpour S, Badiee A, Arabi L, Hoda Alavizadeh S, et al. Nanocarriers call the last shot in the treatment of brain cancers. Technol Cancer Res Treat. 2022;21:15330338221080974.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"3283_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020195","volume":"13","author":"JF Hsu","year":"2021","unstructured":"Hsu JF, Chu SM, Liao CC, Wang CJ, Wang YS, Lai MY, et al. Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update. Cancers (Basel). 2021;13(2):195.","journal-title":"Cancers (Basel)"},{"key":"3283_CR99","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2016.02.026","volume":"227","author":"R Karim","year":"2016","unstructured":"Karim R, Palazzo C, Evrard B, Piel G. Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. J Control Release. 2016;227:23\u201337.","journal-title":"J Control Release"},{"issue":"1","key":"3283_CR100","first-page":"58","volume":"18","author":"B Khameneh","year":"2015","unstructured":"Khameneh B, Halimi V, Jaafari MR, Golmohammadzadeh S. Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications. Iran J Basic Med Sci. 2015;18(1):58.","journal-title":"Iran J Basic Med Sci"},{"key":"3283_CR101","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"W Mehnert","year":"2012","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012;64:83\u2013101.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"3283_CR102","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","volume":"59","author":"P Blasi","year":"2007","unstructured":"Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59(6):454\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"3283_CR103","first-page":"1","volume":"4","author":"DM Small","year":"1986","unstructured":"Small DM. The physical chemistry of lipids from alkanes to phospholipids. Handbook of lipid research. 1986;4:1\u2013672.","journal-title":"Handbook of lipid research"},{"issue":"3","key":"3283_CR104","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","volume":"87","author":"L Gastaldi","year":"2014","unstructured":"Gastaldi L, Battaglia L, Peira E, Chirio D, Muntoni E, Solazzi I, et al. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art. Eur J Pharm Biopharm. 2014;87(3):433\u201344.","journal-title":"Eur J Pharm Biopharm"},{"key":"3283_CR105","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","volume":"264","author":"C Tapeinos","year":"2017","unstructured":"Tapeinos C, Battaglini M, Ciofani G. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Control Release. 2017;264:306\u201332.","journal-title":"J Control Release"},{"issue":"4","key":"3283_CR106","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1049\/iet-nbt.2018.5322","volume":"13","author":"A Anand","year":"2019","unstructured":"Anand A, Sugumaran A, Narayanasamy D. Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles. IET Nanobiotechnol. 2019;13(4):353\u201362.","journal-title":"IET Nanobiotechnol"},{"key":"3283_CR107","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00210-020-02015-9","volume":"394","author":"SRK Pandian","year":"2021","unstructured":"Pandian SRK, Pavadai P, Vellaisamy S, Ravishankar V, Palanisamy P, Sundar LM, et al. Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:735\u201349.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3283_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111946","volume":"206","author":"G Ak","year":"2021","unstructured":"Ak G, \u00dcnal A, Karakayal\u0131 T, \u00d6zel B, G\u00fcnel NS, \u015eanl\u0131er \u015eH. Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture. Colloids Surf B Biointerfaces. 2021;206:111946.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"3283_CR109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/1061186X.2016.1184272","volume":"25","author":"X Li","year":"2017","unstructured":"Li X, Tsibouklis J, Weng T, Zhang B, Yin G, Feng G, et al. Nano carriers for drug transport across the blood\u2013brain barrier. J Drug Target. 2017;25(1):17\u201328.","journal-title":"J Drug Target"},{"key":"3283_CR110","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1023\/A:1016121319668","volume":"19","author":"B Heurtault","year":"2002","unstructured":"Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19:875\u201380.","journal-title":"Pharm Res"},{"issue":"1","key":"3283_CR111","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0928-0987(02)00241-5","volume":"18","author":"B Heurtault","year":"2003","unstructured":"Heurtault B, Saulnier P, Pech B, Venier-Julienne MC, Proust JE, Phan-Tan-Luu R, et al. The influence of lipid nanocapsule composition on their size distribution. Eur J Pharm Sci. 2003;18(1):55\u201361.","journal-title":"Eur J Pharm Sci"},{"issue":"29","key":"3283_CR112","doi-asserted-by":"publisher","first-page":"7542","DOI":"10.1016\/j.biomaterials.2010.06.024","volume":"31","author":"A Paillard","year":"2010","unstructured":"Paillard A, Hindr\u00e9 F, Vignes-Colombeix C, Benoit JP, Garcion E. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials. 2010;31(29):7542\u201354.","journal-title":"Biomaterials"},{"issue":"2","key":"3283_CR113","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","volume":"379","author":"NT Huynh","year":"2009","unstructured":"Huynh NT, Passirani C, Saulnier P, Beno\u00eet JP. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009;379(2):201\u20139.","journal-title":"Int J Pharm"},{"issue":"7","key":"3283_CR114","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","volume":"5","author":"E Garcion","year":"2006","unstructured":"Garcion E, Lamprecht A, Heurtault B, Paillard A, Aubert-Pouessel A, Denizot B, et al. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther. 2006;5(7):1710\u201322.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"3283_CR115","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2006.02.014","volume":"112","author":"A Lamprecht","year":"2006","unstructured":"Lamprecht A, Benoit JP. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release. 2006;112(2):208\u201313.","journal-title":"J Control Release"},{"issue":"2","key":"3283_CR116","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jconrel.2008.05.027","volume":"130","author":"E Allard","year":"2008","unstructured":"Allard E, Passirani C, Garcion E, Pigeon P, Vessi\u00e8res A, Jaouen G, et al. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J Control Release. 2008;130(2):146\u201353.","journal-title":"J Control Release"},{"issue":"8","key":"3283_CR117","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.nano.2014.05.002","volume":"10","author":"AL Lain\u00e9","year":"2014","unstructured":"Lain\u00e9 AL, Clavreul A, Rousseau A, T\u00e9taud C, Vessieres A, Garcion E, et al. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules. Nanomed Nanotechnol Biol Med. 2014;10(8):1667\u201377.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"2","key":"3283_CR118","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpb.2012.10.019","volume":"83","author":"A Zanotto-Filho","year":"2013","unstructured":"Zanotto-Filho A, Coradini K, Braganhol E, Schr\u00f6der R, De Oliveira CM, Sim\u00f5es-Pires A, et al. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm. 2013;83(2):156\u201367.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"3283_CR119","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","volume":"64","author":"T Patel","year":"2012","unstructured":"Patel T, Zhou J, Piepmeier JM, Saltzman WM. Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):701\u20135.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3283_CR120","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","volume":"161","author":"S Wohlfart","year":"2012","unstructured":"Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood\u2013brain barrier by nanoparticles. J Control Release. 2012;161(2):264\u201373.","journal-title":"J Control Release"},{"issue":"11","key":"3283_CR121","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1248\/cpb.58.1423","volume":"58","author":"K Nagpal","year":"2010","unstructured":"Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull. 2010;58(11):1423\u201330.","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"3283_CR122","first-page":"2","volume":"41","author":"P Couvreur","year":"1995","unstructured":"Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm. 1995;41(1):2\u201313.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3283_CR123","first-page":"1","volume":"5","author":"P Couvreur","year":"1988","unstructured":"Couvreur P. Polyalkylcyanoacrylates as colloidal drug carriers. Crit Rev Ther Drug Carrier Syst. 1988;5(1):1\u201320.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"3283_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.021","volume":"331","author":"J Kreuter","year":"2007","unstructured":"Kreuter J. Nanoparticles\u2014a historical perspective. Int J Pharm. 2007;331(1):1\u201310.","journal-title":"Int J Pharm"},{"issue":"2","key":"3283_CR125","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1517\/17425247.5.2.155","volume":"5","author":"G Tosi","year":"2008","unstructured":"Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv. 2008;5(2):155\u201374.","journal-title":"Expert Opin Drug Deliv"},{"key":"3283_CR126","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1023\/A:1018983904537","volume":"16","author":"AE Gulyaev","year":"1999","unstructured":"Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res. 1999;16:1564\u20139.","journal-title":"Pharm Res"},{"key":"3283_CR127","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s11095-005-8343-0","volume":"22","author":"D Shenoy","year":"2005","unstructured":"Shenoy D, Little S, Langer R, Amiji M. Poly (ethylene oxide)-modified poly (\u03b2-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies. Pharm Res. 2005;22:2107\u201314.","journal-title":"Pharm Res"},{"issue":"1","key":"3283_CR128","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0168-3659(97)00061-8","volume":"49","author":"J Kreuter","year":"1997","unstructured":"Kreuter J, Petrov VE, Kharkevich DA, Alyautdin RN. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood\u2013brain barrier using surfactant-coated nanoparticles. J Control Release. 1997;49(1):81\u20137.","journal-title":"J Control Release"},{"issue":"3","key":"3283_CR129","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5414\/NPP28153","volume":"28","author":"T Hekmatara","year":"2009","unstructured":"Hekmatara T, Bernreuther C, Khalansky AS, Theisen A, Weissenberger J, Matschke J, et al. Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects. Clin Neuropathol. 2009;28(3):153\u201364.","journal-title":"Clin Neuropathol"},{"issue":"3","key":"3283_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032568","volume":"7","author":"S Wagner","year":"2012","unstructured":"Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, et al. Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS One. 2012;7(3):e32568.","journal-title":"PLoS One"},{"key":"3283_CR131","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s11095-013-1156-7","volume":"30","author":"S Bozda\u011f Pehlivan","year":"2013","unstructured":"Bozda\u011f Pehlivan S. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases. Pharm Res. 2013;30:2499\u2013511.","journal-title":"Pharm Res"},{"issue":"1","key":"3283_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/srep02534","volume":"3","author":"H Gao","year":"2013","unstructured":"Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep. 2013;3(1):2534.","journal-title":"Sci Rep"},{"issue":"5","key":"3283_CR133","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/02652040600788080","volume":"23","author":"A Ambruosi","year":"2006","unstructured":"Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly (butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul. 2006;23(5):582\u201392.","journal-title":"J Microencapsul"},{"issue":"1","key":"3283_CR134","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2006.10.015","volume":"117","author":"B Petri","year":"2007","unstructured":"Petri B, Bootz A, Khalansky A, Hekmatara T, M\u00fcller R, Uhl R, et al. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release. 2007;117(1):51\u20138.","journal-title":"J Control Release"},{"issue":"5","key":"3283_CR135","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ijc.20048","volume":"109","author":"SC Steiniger","year":"2004","unstructured":"Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer. 2004;109(5):759\u201367.","journal-title":"Int J Cancer"},{"issue":"2","key":"3283_CR136","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1166\/jns.2009.1003","volume":"1","author":"S Wohlfart","year":"2009","unstructured":"Wohlfart S, Bernreuther C, Khalansky AS, Theisen A, Weissenberger J, Gelperina S, et al. Increased numbers of injections of doxorubicin bound to nanoparticles lead to enhanced efficacy against rat glioblastoma 101\/8. J Nanoneurosci. 2009;1(2):144\u201351.","journal-title":"J Nanoneurosci"},{"issue":"2","key":"3283_CR137","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10611860600636135","volume":"14","author":"A Ambruosi","year":"2006","unstructured":"Ambruosi A, Khalansky AS, Yamamoto H, Gelperina SE, Begley DJ, Kreuter J. Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly (butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats. J Drug Target. 2006;14(2):97\u2013105.","journal-title":"J Drug Target"},{"issue":"1","key":"3283_CR138","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2011.05.010","volume":"154","author":"S Wohlfart","year":"2011","unstructured":"Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J. Kinetics of transport of doxorubicin bound to nanoparticles across the blood\u2013brain barrier. J Control Release. 2011;154(1):103\u20137.","journal-title":"J Control Release"},{"issue":"1","key":"3283_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/1061186X.2016.1184272","volume":"25","author":"X Li","year":"2017","unstructured":"Li X, Tsibouklis J, Weng T, Zhang B, Yin G, Feng G, et al. Nano carriers for drug transport across the blood\u2013brain barrier. J Drug Target. 2017;25(1):17\u201328.","journal-title":"J Drug Target"},{"key":"3283_CR140","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev. 2014;71:2\u201314.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"3283_CR141","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/cas.12960","volume":"107","author":"N Nishiyama","year":"2016","unstructured":"Nishiyama N, Matsumura Y, Kataoka K. Development of polymeric micelles for targeting intractable cancers. Cancer Sci. 2016;107(7):867\u201374.","journal-title":"Cancer Sci"},{"key":"3283_CR142","doi-asserted-by":"crossref","unstructured":"Huang, Y., Sun, J., & Li, S. (2017). Rational Design of Polymeric Micelle for Cancer Therapy. In\u00a0Novel Approaches for Drug Delivery\u00a0(pp. 311\u2013336). IGI Global.","DOI":"10.4018\/978-1-5225-0751-2.ch012"},{"key":"3283_CR143","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.colsurfb.2013.07.031","volume":"112","author":"V Saxena","year":"2013","unstructured":"Saxena V, Hussain MD. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme. Colloids Surf, B. 2013;112:350\u20135.","journal-title":"Colloids Surf, B"},{"issue":"5","key":"3283_CR144","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/cbdd.13486","volume":"93","author":"S Talaei","year":"2019","unstructured":"Talaei S, Mellatyar H, Asadi A, Akbarzadeh A, Sheervalilou R, Zarghami N. Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment. Chem Biol Drug Des. 2019;93(5):760\u201386.","journal-title":"Chem Biol Drug Des"},{"key":"3283_CR145","doi-asserted-by":"crossref","unstructured":"Sun, P., Xiao, Y., Di, Q., Ma, W., Ma, X., Wang, Q., & Chen, W. Transferrin receptor-targeted PEG-PLA polymeric micelles for chemotherapy against glioblastoma multiforme.\u00a0Int j nanomed. 2020;6673\u20136688.","DOI":"10.2147\/IJN.S257459"},{"issue":"4","key":"3283_CR146","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ntno.38954","volume":"3","author":"C Liu","year":"2019","unstructured":"Liu C, Zhao Z, Gao H, Rostami I, You Q, Jia X, et al. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly (amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics. 2019;3(4):311.","journal-title":"Nanotheranostics"},{"issue":"12","key":"3283_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120790","volume":"9","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Liu C, Pang Z. Dendrimer-based drug delivery systems for brain targeting. Biomolecules. 2019;9(12):790.","journal-title":"Biomolecules"},{"issue":"2","key":"3283_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10160","volume":"5","author":"K Liaw","year":"2020","unstructured":"Liaw K, Zhang F, Mangraviti A, Kannan S, Tyler B, Kannan RM. Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. Bioeng Transl Med. 2020;5(2):e10160.","journal-title":"Bioeng Transl Med"},{"issue":"13","key":"3283_CR149","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1021\/jo0503254","volume":"70","author":"LS Kaanumalle","year":"2005","unstructured":"Kaanumalle LS, Ramesh R, Murthy Maddipatla VSN, Nithyanandhan J, Jayaraman N, Ramamurthy V. Dendrimers as photochemical reaction media. Photochemical behavior of unimolecular and bimolecular reactions in water-soluble dendrimers. J Org Chem. 2005;70(13):5062\u20139.","journal-title":"J Org Chem"},{"issue":"11","key":"3283_CR150","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1021\/jo00211a052","volume":"50","author":"GR Newkome","year":"1985","unstructured":"Newkome GR, Yao Z, Baker GR, Gupta VK. Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol. J Org Chem. 1985;50(11):2003\u20134.","journal-title":"J Org Chem"},{"issue":"4","key":"3283_CR151","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1096\/fj.06-7380com","volume":"21","author":"RQ Huang","year":"2007","unstructured":"Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J. 2007;21(4):1117\u201325.","journal-title":"FASEB J"},{"issue":"10","key":"3283_CR152","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1002\/jps.23672","volume":"102","author":"AM O\u2019Mahony","year":"2013","unstructured":"O\u2019Mahony AM, Godinho BM, Cryan JF, O\u2019Driscoll CM. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution. J Pharm Sci. 2013;102(10):3469\u201384.","journal-title":"J Pharm Sci"},{"key":"3283_CR153","unstructured":"Hermanson, G. T.\u00a0Bioconjugate techniques. Academic press. 2013."},{"key":"3283_CR154","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejps.2015.06.024","volume":"78","author":"A Zarebkohan","year":"2015","unstructured":"Zarebkohan A, Najafi F, Moghimi HR, Hemmati M, Deevband MR, Kazemi B. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain. Eur J Pharm Sci. 2015;78:19\u201330.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"3283_CR155","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","volume":"32","author":"H He","year":"2011","unstructured":"He H, Li Y, Jia XR, Du J, Ying X, Lu WL, et al. Pegylated poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials. 2011;32(2):478\u201387.","journal-title":"Biomaterials"},{"issue":"8","key":"3283_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23082028","volume":"23","author":"P Stenstr\u00f6m","year":"2018","unstructured":"Stenstr\u00f6m P, Manzanares D, Zhang Y, Ce\u00f1a V, Malkoch M. Evaluation of amino-functional polyester dendrimers based on Bis-MPA as nonviral vectors for siRNA delivery. Molecules. 2018;23(8):2028.","journal-title":"Molecules"},{"issue":"20","key":"3283_CR157","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.2174\/1381612823666170314104619","volume":"23","author":"V Tambe","year":"2017","unstructured":"Tambe V, Thakkar S, Raval N, Sharma D, Kalia K, Tekade RK. Surface engineered dendrimers in siRNA delivery and gene silencing. Curr Pharm Des. 2017;23(20):2952\u201375.","journal-title":"Curr Pharm Des"},{"key":"3283_CR158","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejps.2018.07.020","volume":"122","author":"M Ghaffari","year":"2018","unstructured":"Ghaffari M, Dehghan G, Abedi-Gaballu F, Kashanian S, Baradaran B, Dolatabadi JEN, et al. Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting. Eur J Pharm Sci. 2018;122:311\u201330.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3283_CR159","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1021\/mp700086j","volume":"5","author":"RS Dhanikula","year":"2008","unstructured":"Dhanikula RS, Argaw A, Bouchard JF, Hildgen P. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol Pharm. 2008;5(1):105\u201316.","journal-title":"Mol Pharm"},{"issue":"23","key":"3283_CR160","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.2217\/nnm-2016-0240","volume":"11","author":"L Kong","year":"2016","unstructured":"Kong L, Wu Y, Alves CS, Shi X. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles. Nanomedicine. 2016;11(23):3103\u201315.","journal-title":"Nanomedicine"},{"key":"3283_CR161","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.actbio.2017.03.055","volume":"55","author":"J Liu","year":"2017","unstructured":"Liu J, Peng Q. Protein-gold nanoparticle interactions and their possible impact on biomedical applications. Acta Biomater. 2017;55:13\u201327.","journal-title":"Acta Biomater"},{"key":"3283_CR162","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S238206","author":"L Peng","year":"2020","unstructured":"Peng L, Liang Y, Zhong X, Liang Z, Tian Y, Li S, et al. Aptamer-conjugated gold nanoparticles targeting epidermal growth factor receptor variant III for the treatment of glioblastoma. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S238206.","journal-title":"Int J Nanomedicine"},{"issue":"9\u201310","key":"3283_CR163","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.drudis.2011.03.004","volume":"16","author":"MM Yallapu","year":"2011","unstructured":"Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discov Today. 2011;16(9\u201310):457\u201363.","journal-title":"Drug Discov Today"},{"key":"3283_CR164","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jconrel.2016.08.029","volume":"239","author":"Z Shatsberg","year":"2016","unstructured":"Shatsberg Z, Zhang X, Ofek P, Malhotra S, Krivitsky A, Scomparin A, et al. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy. J Control Release. 2016;239:159\u201368.","journal-title":"J Control Release"},{"issue":"11","key":"3283_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111516","volume":"9","author":"B Javed","year":"2021","unstructured":"Javed B, Zhao X, Cui D, Curtin J, Tian F. Enhanced anticancer response of curcumin-and piperine-loaded lignin-GP (NIPAM-co-DMAEMA) gold nanogels against U-251 MG glioblastoma multiforme. Biomedicines. 2021;9(11):1516.","journal-title":"Biomedicines"},{"issue":"1","key":"3283_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34462-8","volume":"13","author":"D Zhang","year":"2022","unstructured":"Zhang D, Tian S, Liu Y, Zheng M, Yang X, Zou Y, et al. Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma. Nat Commun. 2022;13(1):6835.","journal-title":"Nat Commun"},{"issue":"22","key":"3283_CR167","doi-asserted-by":"publisher","first-page":"14145","DOI":"10.1021\/acsnano.3c03409","volume":"18","author":"P Dosta","year":"2024","unstructured":"Dosta P, Dion MZ, Prado M, Hurtado P, Riojas-Javelly CJ, Cryer AM, et al. Matrix metalloproteinase-and pH-sensitive nanoparticle system enhances drug retention and penetration in glioblastoma. ACS Nano. 2024;18(22):14145\u201360.","journal-title":"ACS Nano"},{"issue":"1","key":"3283_CR168","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1021\/acs.molpharmaceut.4c00708","volume":"22","author":"H Slika","year":"2024","unstructured":"Slika H, Shahani A, Gattu K, Mundrathi V, Solan AA, Gonzalez B, et al. Intracranial nanogel pellets carrying temozolomide and paclitaxel for adjuvant brain cancer therapy. Mol Pharm. 2024;22(1):131\u201341.","journal-title":"Mol Pharm"},{"issue":"6","key":"3283_CR169","doi-asserted-by":"publisher","first-page":"882","DOI":"10.2174\/1871520618666180131112914","volume":"18","author":"A Neshastehriz","year":"2018","unstructured":"Neshastehriz A, Khateri M, Ghaznavi H, Shakeri-Zadeh A. Investigating the therapeutic effects of alginate nanogel co-loaded with gold nanoparticles and cisplatin on U87-MG human glioblastoma cells. Anti-Cancer Agents Med Chem. 2018;18(6):882\u201390.","journal-title":"Anti-Cancer Agents Med Chem"},{"issue":"7","key":"3283_CR170","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.nano.2013.04.007","volume":"9","author":"L Bobyk","year":"2013","unstructured":"Bobyk L, Edouard M, Deman P, Vautrin M, Pernet-Gallay K, Delaroche J, et al. Photoactivation of gold nanoparticles for glioma treatment. Nanomedicine Nanotechnol Biol Med. 2013;9(7):1089\u201397.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"9","key":"3283_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/nano8090634","volume":"8","author":"M Ajdary","year":"2018","unstructured":"Ajdary M, Moosavi MA, Rahmati M, Falahati M, Mahboubi M, Mandegary A, et al. Health concerns of various nanoparticles: a review of their in vitro and in vivo toxicity. Nanomaterials. 2018;8(9):634.","journal-title":"Nanomaterials"},{"key":"3283_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119342","volume":"218","author":"UK Sukumar","year":"2019","unstructured":"Sukumar UK, Bose RJ, Malhotra M, Babikir HA, Afjei R, Robinson E, et al. Intranasal delivery of targeted polyfunctional gold\u2013iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials. 2019;218:119342.","journal-title":"Biomaterials"},{"key":"3283_CR173","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuro.2015.03.006","volume":"48","author":"T Coccini","year":"2015","unstructured":"Coccini T, Grandi S, Lonati D, Locatelli C, De Simone U. Comparative cellular toxicity of titanium dioxide nanoparticles on human astrocyte and neuronal cells after acute and prolonged exposure. Neurotoxicology. 2015;48:77\u201389.","journal-title":"Neurotoxicology"},{"issue":"19","key":"3283_CR174","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201704307","volume":"30","author":"J Bourquin","year":"2018","unstructured":"Bourquin J, Milosevic A, Hauser D, Lehner R, Blank F, Petri-Fink A, et al. Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv Mater. 2018;30(19):1704307.","journal-title":"Adv Mater"},{"issue":"8","key":"3283_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/nano7080230","volume":"7","author":"R Kr\u0119towski","year":"2017","unstructured":"Kr\u0119towski R, Kusaczuk M, Naumowicz M, Koty\u0144ska J, Szynaka B, Cechowska-Pasko M. The effects of silica nanoparticles on apoptosis and autophagy of glioblastoma cell lines. Nanomaterials. 2017;7(8):230.","journal-title":"Nanomaterials"},{"issue":"6","key":"3283_CR176","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.nano.2015.03.004","volume":"11","author":"IY Kim","year":"2015","unstructured":"Kim IY, Joachim E, Choi H, Kim K. Toxicity of silica nanoparticles depends on size, dose, and cell type. Nanomedicine Nanotechnol Biol Med. 2015;11(6):1407\u201316.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"3283_CR177","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nano.2018.11.013","volume":"16","author":"M Yazdimamaghani","year":"2019","unstructured":"Yazdimamaghani M, Moos PJ, Dobrovolskaia MA, Ghandehari H. Genotoxicity of amorphous silica nanoparticles: status and prospects. Nanomedicine Nanotechnol Biol Med. 2019;16:106\u201325.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"3283_CR178","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S276105","author":"X Dong","year":"2020","unstructured":"Dong X, Wu Z, Li X, Xiao L, Yang M, Li Y, et al. The size-dependent cytotoxicity of amorphous silica nanoparticles: a systematic review of in vitro studies. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S276105.","journal-title":"Int J Nanomedicine"},{"issue":"37","key":"3283_CR179","doi-asserted-by":"publisher","first-page":"33637","DOI":"10.1021\/acsami.9b10787","volume":"11","author":"M Luo","year":"2019","unstructured":"Luo M, Lewik G, Ratcliffe JC, Choi CHJ, Makila E, Tong WY, et al. Systematic evaluation of transferrin-modified porous silicon nanoparticles for targeted delivery of doxorubicin to glioblastoma. ACS Appl Mater Interfaces. 2019;11(37):33637\u201349.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3283_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59146-5","volume":"10","author":"S Sheykhzadeh","year":"2020","unstructured":"Sheykhzadeh S, Luo M, Peng B, White J, Abdalla Y, Tang T, et al. Transferrin-targeted porous silicon nanoparticles reduce glioblastoma cell migration across tight extracellular space. Sci Rep. 2020;10(1):2320.","journal-title":"Sci Rep"},{"issue":"11","key":"3283_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.201900118","volume":"2","author":"O Turan","year":"2019","unstructured":"Turan O, Bielecki PA, Perera V, Lorkowski M, Covarrubias G, Tong K, et al. Treatment of glioblastoma using multicomponent silica nanoparticles. Adv Ther. 2019;2(11):1900118.","journal-title":"Adv Ther"},{"key":"3283_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119582","volume":"586","author":"M Azarmi","year":"2020","unstructured":"Azarmi M, Maleki H, Nikkam N, Malekinejad H. Transcellular brain drug delivery: a review on recent advancements. Int J Pharm. 2020;586:119582.","journal-title":"Int J Pharm"},{"issue":"10","key":"3283_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/ph13100319","volume":"13","author":"E Romano","year":"2020","unstructured":"Romano E, Netti PA, Torino E. Exosomes in gliomas: biogenesis, isolation, and preliminary applications in nanomedicine. Pharmaceuticals. 2020;13(10):319.","journal-title":"Pharmaceuticals"},{"key":"3283_CR184","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2017.07.001","volume":"262","author":"D Rufino-Ramos","year":"2017","unstructured":"Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ, de Almeida LP. Extracellular vesicles: novel promising delivery systems for therapy of brain diseases. J Control Release. 2017;262:247\u201358.","journal-title":"J Control Release"},{"issue":"18","key":"3283_CR185","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2217\/nnm-2016-0154","volume":"11","author":"M Hadla","year":"2016","unstructured":"Hadla M, Palazzolo S, Corona G, Caligiuri I, Canzonieri V, Toffoli G, et al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine. 2016;11(18):2431\u201341.","journal-title":"Nanomedicine"},{"issue":"4","key":"3283_CR186","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"3283_CR187","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.18632\/aging.202424","volume":"13","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Guo X, Guo X, Yu R, Qian M, Wang S, et al. Microrna-29a-3p delivery via exosomes derived from engineered human mesenchymal stem cells exerts tumour suppressive effects by inhibiting migration and vasculogenic mimicry in glioma. Aging (Albany NY). 2021;13(4):5055.","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"3283_CR188","doi-asserted-by":"publisher","first-page":"19243","DOI":"10.18632\/aging.203243","volume":"13","author":"J Jiang","year":"2021","unstructured":"Jiang J, Lu J, Wang X, Sun B, Liu X, Ding Y, et al. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT\/ERK signaling. Aging (Albany NY). 2021;13(15):19243.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"3283_CR189","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12195-016-0456-0","volume":"9","author":"CC Chen","year":"2016","unstructured":"Chen CC, Liu L, Ma F, Wong CW, Guo XE, Chacko JV, et al. Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol Bioeng. 2016;9(4):509\u201329. https:\/\/doi.org\/10.1007\/s12195-016-0456-0.","journal-title":"Cell Mol Bioeng"},{"issue":"11","key":"3283_CR190","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","volume":"33","author":"H Xin","year":"2013","unstructured":"Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33(11):1711\u20135. https:\/\/doi.org\/10.1038\/jcbfm.2013.152.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3283_CR191","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3171\/2014.11.JNS14770","volume":"122","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 2015;122(4):856\u201367. https:\/\/doi.org\/10.3171\/2014.11.JNS14770.","journal-title":"J Neurosurg"},{"key":"3283_CR192","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.031","volume":"178","author":"G Jia","year":"2018","unstructured":"Jia G, Han Y, An Y, Ding Y, He C, Wang X, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302\u201316. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.06.031.","journal-title":"Biomaterials"},{"issue":"3","key":"3283_CR193","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10571-015-0238-5","volume":"36","author":"M Katakowski","year":"2016","unstructured":"Katakowski M, Chopp M. Exosomes as tools to suppress primary brain tumor. Cell Mol Neurobiol. 2016;36(3):343\u201352. https:\/\/doi.org\/10.1007\/s10571-015-0238-5.","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"3283_CR194","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12031-015-0555-5","volume":"56","author":"N Bu","year":"2015","unstructured":"Bu N, Wu H, Zhang G, Zhan S, Zhang R, Sun H, et al. Exosomes from dendritic cells loaded with chaperone-rich cell lysates elicit a potent T cell immune response against intracranial glioma in mice. J Mol Neurosci. 2015;56(3):631\u201343. https:\/\/doi.org\/10.1007\/s12031-015-0555-5.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"3283_CR195","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2217\/nnm-2019-0317","volume":"15","author":"JJ Mulvihill","year":"2020","unstructured":"Mulvihill JJ, Cunnane EM, Ross AM, Duskey JT, Tosi G, Grabrucker AM. Drug delivery across the blood-brain barrier: Recent advances in the use of nanocarriers. Nanomedicine (London). 2020;15(2):205\u201314. https:\/\/doi.org\/10.2217\/nnm-2019-0317.","journal-title":"Nanomedicine (London)"},{"issue":"6","key":"3283_CR196","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","volume":"32","author":"T Yang","year":"2015","unstructured":"Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32(6):2003\u201314. https:\/\/doi.org\/10.1007\/s11095-014-1593-y.","journal-title":"Pharm Res"},{"key":"3283_CR197","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jconrel.2020.07.007","volume":"326","author":"S Salunkhe","year":"2020","unstructured":"Salunkhe S, Basak M, Chitkara D, Mittal A. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance. J Control Release. 2020;326:599\u2013614. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.007.","journal-title":"J Control Release"},{"issue":"7","key":"3283_CR198","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","volume":"35","author":"Y Tian","year":"2014","unstructured":"Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383\u201390. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.11.083.","journal-title":"Biomaterials"},{"issue":"2","key":"3283_CR199","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s12035-015-9099-1","volume":"53","author":"A Aryani","year":"2016","unstructured":"Aryani A, Denecke B. Exosomes as a nanodelivery system: a key to the future of neuromedicine? Mol Neurobiol. 2016;53(2):818\u201334. https:\/\/doi.org\/10.1007\/s12035-015-9099-1.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3283_CR200","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-021-01073-6","volume":"14","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: Current progress and perspectives. J Hematol Oncol. 2021;14(1):85. https:\/\/doi.org\/10.1186\/s13045-021-01073-6.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3283_CR201","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.copbio.2011.05.502","volume":"22","author":"JA MacDiarmid","year":"2011","unstructured":"MacDiarmid JA, Brahmbhatt H. Minicells: versatile vectors for targeted drug or si\/shRNA cancer therapy. Curr Opin Biotechnol. 2011;22(6):909\u201316. https:\/\/doi.org\/10.1016\/j.copbio.2011.05.502.","journal-title":"Curr Opin Biotechnol"},{"key":"3283_CR202","doi-asserted-by":"publisher","unstructured":"Parti, R. P., Biswas, D., Wang, M., Liao, M., & Dillon, J. A.\u00a0 A minD mutant of enterohemorrhagic E. coli O157:H7 has reduced adherence to human epithelial cells. Microb Pathog. 2011;51(5): 378\u2013383. https:\/\/doi.org\/10.1016\/j.micpath.2011.09.005","DOI":"10.1016\/j.micpath.2011.09.005"},{"issue":"3","key":"3283_CR203","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.mimet.2012.12.016","volume":"92","author":"M Jivrajani","year":"2013","unstructured":"Jivrajani M, Shrivastava N, Nivsarkar M. A combination approach for rapid and high yielding purification of bacterial minicells. J Microbiol Methods. 2013;92(3):340\u20133. https:\/\/doi.org\/10.1016\/j.mimet.2012.12.016.","journal-title":"J Microbiol Methods"},{"issue":"4","key":"3283_CR204","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4014\/jmb.1411.11030","volume":"25","author":"JY Lee","year":"2015","unstructured":"Lee JY, Choy HE, Lee JH, Kim GJ. Generation of minicells from an endotoxin-free Gram-positive strain Corynebacterium glutamicum. J Microbiol Biotechnol. 2015;25(4):554\u20138. https:\/\/doi.org\/10.4014\/jmb.1411.11030.","journal-title":"J Microbiol Biotechnol"},{"issue":"10","key":"3283_CR205","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.addr.2013.05.009","volume":"65","author":"R van der Meel","year":"2013","unstructured":"van der Meel R, Vehmeijer LJ, Kok RJ, Storm G, van Gaal EV. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Deliv Rev. 2013;65(10):1284\u201398. https:\/\/doi.org\/10.1016\/j.addr.2013.05.009.","journal-title":"Adv Drug Deliv Rev"},{"key":"3283_CR206","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2020.07.024","volume":"491","author":"MK Ali","year":"2020","unstructured":"Ali MK, Liu Q, Liang K, Li P, Kong Q. Bacteria-derived minicells for cancer therapy. Cancer Lett. 2020;491:11\u201321. https:\/\/doi.org\/10.1016\/j.canlet.2020.07.024.","journal-title":"Cancer Lett"},{"key":"3283_CR207","doi-asserted-by":"publisher","unstructured":"Camilla, U. R., Proenca, A., Buetz, C., Shi, C., Chao, L., & Bowman, G. R. Minicells as a damage disposal mechanism in Escherichia coli. mSphere. 2018;3(5): e00428\u201318. https:\/\/doi.org\/10.1128\/mSphere.00428-18","DOI":"10.1128\/mSphere.00428-18"},{"issue":"1","key":"3283_CR208","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10020-021-00286-8","volume":"27","author":"MB Khan","year":"2021","unstructured":"Khan MB, Ruggieri R, Jamil E, Tran NL, Gonzalez C, Mugridge N, et al. Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma. Mol Med. 2021;27(1):28. https:\/\/doi.org\/10.1186\/s10020-021-00286-8.","journal-title":"Mol Med"},{"key":"3283_CR209","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020190","author":"S Akg\u00fcl","year":"2019","unstructured":"Akg\u00fcl S, Patch AM, D\u2019Souza RCJ, Mukhopadhyay P, Nones K, Kempe S, et al. Intratumoural heterogeneity underlies distinct therapy responses and treatment resistance in glioblastoma. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11020190.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3283_CR210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151832","volume":"11","author":"JA MacDiarmid","year":"2016","unstructured":"MacDiarmid JA, Langova V, Bailey D, Pattison ST, Pattison SL, Christensen N, et al. Targeted doxorubicin delivery to brain tumors via minicells: proof of principle using dogs with spontaneously occurring tumors as a model. PLoS One. 2016;11(4):e0151832. https:\/\/doi.org\/10.1371\/journal.pone.0151832.","journal-title":"PLoS One"},{"issue":"6","key":"3283_CR211","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/neuonc\/nox204","volume":"20","author":"E Eskilsson","year":"2018","unstructured":"Eskilsson E, R\u00f8sland GV, Solecki G, Wang Q, Harter PN, Graziani G, et al. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma. Neuro Oncol. 2018;20(6):743\u201352. https:\/\/doi.org\/10.1093\/neuonc\/nox204.","journal-title":"Neuro Oncol"},{"issue":"1","key":"3283_CR212","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/acs.nanolett.8b03093","volume":"19","author":"X Wang","year":"2019","unstructured":"Wang X, Wang X, Bai X, Yan L, Liu T, Wang M, et al. Nanoparticle ligand exchange and its effects at the nanoparticle-cell membrane interface. Nano Lett. 2019;19(1):8\u201318. https:\/\/doi.org\/10.1021\/acs.nanolett.8b03093.","journal-title":"Nano Lett"},{"issue":"8","key":"3283_CR213","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s11427-020-1633-1","volume":"63","author":"X Wang","year":"2020","unstructured":"Wang X, Cui X, Zhao Y, Chen C. Nano-bio interactions: the implication of size-dependent biological effects of nanomaterials. Sci China Life Sci. 2020;63(8):1168\u201382. https:\/\/doi.org\/10.1007\/s11427-020-1633-1.","journal-title":"Sci China Life Sci"},{"issue":"7","key":"3283_CR214","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrd2352","volume":"6","author":"A Flemming","year":"2007","unstructured":"Flemming A. Minicells deliver lethal load to tumours. Nat Rev Drug Discov. 2007;6(7):519. https:\/\/doi.org\/10.1038\/nrd2352.","journal-title":"Nat Rev Drug Discov"},{"key":"3283_CR215","unstructured":"https:\/\/clinicaltrials.gov\/search?cond=Glioblastoma"},{"key":"3283_CR216","unstructured":"https:\/\/patents.google.com\/"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03283-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:02:30Z","timestamp":1770318150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":216,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03283-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors confirm that no paper mill and no artificial intelligence were used.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"40"}}